Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis.
Eirini K. Argyri, Joy Krecké, Oliver Robinson, J. Evans, Michael Skragge, C. J. A. Morgan
Harm Reduction Journal December 9, 2025 DOI: 10.1186/s12954-025-01347-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 28 |
| Population | Professionals who support individuals navigating post-psychedelic distress, including psychiatrists, psychotherapists, psychedelic integration coaches, and retreat facilitators |
| Topics | Psychedelic-assisted therapy |
| Keywords | Humans Hallucinogens Psychotherapy Qualitative research Adult Middle aged Female Integration Harm reduction Existential crisis Psychedelics Trauma-informed care Post-psychedelic distress |
| Citations | 4 |
| Key findings | Practitioners reported six key post-psychedelic difficulties—existential struggle and ontological shock, anxiety and panic, self-perception issues, dissociative symptoms, resurfacing of repressed material and trauma, and disappointment due to unmet expectations—and most often recommended individual psychotherapy (particularly trauma-informed), grounding and mindfulness techniques, peer and community support, meaning-making and narrative reconstruction, and in some cases short-term psychiatric medication. The authors argue for trauma-informed, cross-disciplinary integration and accessible, ethical, evidence-based support as psychedelic use expands. |
Abstract
Background: As the use of psychedelics increases in both therapeutic and non-clinical settings, reports of extended post-experience difficulties have also emerged. While many individuals integrate their experiences effectively, others face persistent challenges. Despite growing recognition of these issues, there is limited research on best practices for mitigating and addressing prolonged post-psychedelic difficulties. This study explores expert perspectives on the nature of these challenges and optimal support strategies.
Methods: A qualitative survey study was conducted with 28 professionals who support individuals navigating post-psychedelic distress, including psychiatrists, psychotherapists, psychedelic integration coaches, and retreat facilitators. Structured Tabular Thematic Analysis (ST-TA) was applied to identify high-consensus themes related to extended difficulties and effective integration practices.
Results: Practitioners consistently reported six key post-psychedelic difficulties: (1) existential struggle and ontological shock, (2) anxiety and panic, (3) self-perception issues, (4) dissociative symptoms, (5) resurfacing of repressed material and trauma, and (6) disappointment due to unmet expectations. The most frequently recommended support strategies included (1) individual psychotherapy, particularly trauma-informed approaches, (2) grounding and mindfulness techniques, (3) peer and community support, (4) meaning-making and narrative reconstruction, and (5) in some cases, short-term psychiatric medication. While psychiatrists emphasized medical stabilization and symptom management, psychotherapists and integration coaches focused on existential meaning-making, emotional processing, and community-based support.
Conclusions: Our findings highlight the need for trauma-informed, cross-disciplinary approaches to psychedelic integration. Ensuring access to ethical, evidence-based support-both clinical and community-based-is important for further developing harm reduction strategies as psychedelic use expands in the western world. Future research should explore culturally diverse integration practices and inform therapeutic protocols for mitigating post-psychedelic distress.
Comparable studies
Other qualitative studies on psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin | 2017 | Qualitative study | n = 20 |
| LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Patients with anxiety associated with life-threatening diseases | 2014 | Prospective follow-up with qualitative content analysis | n = 10 |
| Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis | 2017 | Qualitative study | n = 13 |
| Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study | 2018 | Qualitative follow-up study using semi-structured interviews and thematic analysis | n = 12 |
| The hidden therapist: evidence for a central role of music in psychedelic therapy Patients undergoing psychedelic therapy with psilocybin for treatment-resistant depression | 2018 | Qualitative study | n = 19 |
Citations in the library
Cited by 6
- Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample. Research Square April 8, 2026
- Safety in an Evolving Psychedelic Landscape: Knowledge and Use of Psilocybin Safety Strategies, Resources, and Support in a Naturalistic Oregon Sample Psychedelics October 1, 2026
- Beyond Access: The SIGNAL Model of Internal Guidance in Psychedelic Preparation and Integration Psychedelics July 1, 2026
- Symptom-Specific Nuances in Psychedelic Integration: A Qualitative Study of Insights from Therapists Supporting Extended Difficulties in Naturalistic Settings Research Square May 21, 2026
- Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled Trial Research Square October 5, 2026
and 1 more in the library
Cites 53
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI) Frontiers in Human Neuroscience June 14, 2016
- Predicting Responses to Psychedelics: A Prospective Study Frontiers in Pharmacology November 2, 2018
- Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. Journal of Psychopharmacology July 11, 2019
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
and 48 more in the library